Replies to post #5291 on Momenta Pharmaceuticals, Inc. (MNTA)

[Regulardoc]

With all the messages about MNTA and its cash hoard and its December 2010 offering, it will be interesting to see what happens if the stock drops below the $14.35 offering price. Will the company repurchase a like number of shares, at perhaps an even lower price to cover costs, thus making it a profitable "round trip?"